PCNA and cancer: The findings suggested that PCNA expression was significantly associated with poor 5-year survival, advanced stage, or higher World Health Organization grade, which indicated it might be a useful prognostic and diagnostic biomarker or an effective therapeutic target in CC or other cancers.